Alan M. Birch

DGAT1 inhibitors as anti-obesity and anti-diabetic agents.

Alan M. Birch, Linda K. Buckett, Andrew V. Turnbull · PubMed · 2010 · 85 citations

Obesity, Metabolic Syndrome, Molecular Pharmacology +14

Discovery of a Potent, Selective, and Orally Efficacious Pyrimidinooxazinyl Bicyclooctaneacetic Acid Diacylglycerol Acyltransferase-1 Inhibitor

Alan M. Birch, Susan Birtles, Linda K. Buckett et al. · Journal of Medicinal Chemistry · 2009 · 75 citations · Full text

Bicyclooctaneacetic Acid Derivative, Pharmacotherapy, Chemical Biology +16

Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation

James S. Scott, Alan M. Birch, Katy J. Brocklehurst et al. · Journal of Medicinal Chemistry · 2012 · 74 citations · Full text

Glycobiology, Chemical Biology, Molecular Recognition +17

Rationally Designing Safer Anilines: The Challenging Case of 4-Aminobiphenyls

Alan M. Birch, Sam D. Groombridge, Robert V. Law et al. · Journal of Medicinal Chemistry · 2012 · 49 citations

Combinatorial Chemistry, Medicinal Chemistry, Designing Safer Anilines +12

<i>N</i>-Substituted (2,3-Dihydro-1,4-benzodioxin-2-yl)methylamine Derivatives as D₂ Antagonists/5-HT_1A Partial Agonists with Potential as Atypical Antipsychotic Agents

Alan M. Birch, Paul A. Bradley, J. C. GILL et al. · Journal of Medicinal Chemistry · 1999 · 46 citations · Full text

Psychotropic Medication, Psychopharmacology, Social Sciences +16